REGISTERED NUMBER: 07059155 (England and Wales)

Unaudited Financial Statements for the Year Ended 31 October 2025

for

Metis Clinical Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTORS:

Mrs A L Morgan

Mr J L V Morgan

REGISTERED OFFICE:

Hine House

25 Regent Street

Nottingham

Nottinghamshire

NG1 5BS

REGISTERED NUMBER:

07059155 (England and Wales)

FIXED ASSETS

Tangible assets

4

20,160

20,797

CURRENT ASSETS

Stocks

1,759

8,694

Debtors

5

105,685

94,141

Cash at bank

969,879

968,285

1,077,323

1,071,120

CREDITORS

Amounts falling due within one year

6

61,761

63,897

NET CURRENT ASSETS

1,015,562

1,007,223

TOTAL ASSETS LESS CURRENT LIABILITIES

1,035,722

1,028,020

CREDITORS

Amounts falling due after more than one year

7

14,430

16,430

NET ASSETS

1,021,292

1,011,590

CAPITAL AND RESERVES

Called up share capital

2

2

Retained earnings

1,021,290

1,011,588

1,021,292

1,011,590

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 2 July 2026 and were signed on its behalf by:

Mrs A L Morgan - Director

1.	STATUTORY INFORMATION

Metis Clinical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Stocks

Work in progress is valued at the lower of cost and net realisable value.

Cost is calculated using the first-in, first-out method and includes all purchase, transport, and handling costs in bringing stocks to their present location and condition.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company contributes to defined contribution pension schemes for directors and employees, and contributions are charged to profit or loss in the period in which they are paid.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2024 - 2 ) .

4.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 November 2024

60,363

Additions

5,410

Disposals

(4,463

)

At 31 October 2025

61,310

DEPRECIATION

At 1 November 2024

39,566

Charge for year

5,610

Eliminated on disposal

(4,026

)

At 31 October 2025

41,150

NET BOOK VALUE

At 31 October 2025

20,160

At 31 October 2024

20,797

5.

DEBTORS

2025

2024

£

£

Amounts falling due within one year:

Trade debtors

48,234

33,317

Other debtors

18,313

60,824

66,547

94,141

Amounts falling due after more than one year:

Other debtors

39,138

-

Aggregate amounts

105,685

94,141

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Hire purchase contracts and finance leases

1,999

1,999

Taxation and social security

41,309

58,474

Other creditors

18,453

3,424

61,761

63,897

7.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2025

2024

£

£

Hire purchase contracts and finance leases

14,430

16,430

8.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

During the year the company loaned monies to the directors and interest at HMRC's prevailing beneficial loan rate was charged and reflected as income in the accounts. The net amount outstanding at the year end was £25,803. (2024 £45,435)